46 Group profit and loss account FOR THE YEAR ENDED 31 DECEMBER 2003 2003 2002 2001 Notes m m m A Turnover 2 169.1 79.7 8.9 Cost of sales 98.4 49.2 5.1 Gross profit 70.7 30.5 3.8 Research and development costs 19.9 16.5 13.0 Sales and marketing costs 1.3 Administrative costs including amortisation of goodwill 3 4.7 4.3 3.5 Exceptional administrative item: settlement of BTG agreement 3,4 7.4 Group operating profit loss 37.4 9.7 12.7 Interest receivable and similar income 2.1 0.7 0.9 Amounts released provided against fixed asset investment 5 0.5 0.1 0.4 Interest payable and similar charges 6 1.0 1.2 0.2 Exchange gain loss on foreign currency borrowings 19 0.4 0.5 0.1 A Profit loss on ordinary activities before taxation 7 39.4 9.6 12.5 B Taxation 10 3.9 0.1 Profit loss on ordinary activities after taxation being retained profit loss for the financial year 35.5 9.6 12.4 Earnings loss per ordinary share basic 11 34.5p 10.0p 13.7 p Earnings loss per ordinary share fully diluted 11 34.0p 9.7p 13.7 p A statement of movements on reserves is given in note 24.
The accompanying notes are an integral part of this Group profit and loss account.
All amounts in 2003 arise from continuing operations.
The results of the Groups acquisition during 2003 are not material to the Group see note 15.
Group statement of total recognised gains and losses FOR THE YEAR ENDED 31 DECEMBER 2003 2003 2002 2001 m m m Profit loss for the year 35.5 9.6 12.4 Loss gain on foreign currency translation 3.8 1.3 0.3 Total recognised gains and losses for the financial year 31.7 10.9 12.7 The accompanying notes are an integral part of this Group statement of total recognised gains and losses.
THE INFORMATION IN THIS BORDER HAS NOT BEEN AUDITED A TURNOVER AND PROFIT LOSS ON ORDINARY B TAXATION C STOCK AND DEBTORS: AMOUNTS RECEIVABLE WITHIN ONE YEAR ACTIVITIES BEFORE TAXATION IN 2003 WE RECORDED A 3.9M TAX CHARGE COMPARED BOTH STOCK AND DEBTORS REDUCED DURING 2003.
AT THE IN 2003, ACAMBIS REPORTED RECORD FINANCIAL RESULTS TO ZERO IN 2002.
ACAMBIS RECORDED ITS MAIDEN PROFITS END OF 2002 THE STOCK BALANCE RELATED TO SMALLPOX WITH ALMOST A FOUR-FOLD INCREASE IN PROFITS BEFORE IN 2002, SINCE WHICH TIME THE MAJORITY OF THE GROUPS VACCINE THAT WAS SHIPPED TO THE CDC DURING 2003.
REVENUE IN THE YEAR INCREASED HISTORIC TAX LOSSES HAVE BEEN UTILISED.
THE EFFECTIVE DEBTORS AT THE END OF 2002 INCLUDED AMOUNTS OWED FROM 79.7M IN 2002 TO 169.1M IN 2003 PRINCIPALLY AS TAX RATE IN 2003 WAS 10%, AND WE EXPECT THIS WILL BY THE CDC UNDER THE SMALLPOX VACCINE CONTRACT A RESULT OF INCREASED ACTIVITY UNDER OUR SMALLPOX INCREASE TO BETWEEN 30% AND 35% IN 2004.
VACCINE PROGRAMME WITH THE CDC.
